Actively Recruiting
Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection
Led by Juventas Cell Therapy Ltd. · Updated on 2025-08-07
1000
Participants Needed
1
Research Sites
834 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial adopts an observational research method to conduct annual follow-up and monitoring of patients receiving treatment with Inaticabtagene Autoleucel Injection after its commercialization, in order to evaluate the delayed adverse events of Inaticabtagene Autoleucel Injection.
CONDITIONS
Official Title
Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Agree to sign an informed consent form for long-term follow-up studies.
- Patients from registered clinical trials with different indications who have received at least one infusion of Inaticabtagene Autoleucel Injection.
- Patients treated with Inaticabtagene Autoleucel Injection after market commercialization.
You will not qualify if you...
- None.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institute of Hematology & Blood Diseases Hospital
Tianjin, Tianjin Municipality, China
Actively Recruiting
Research Team
Y
Yinling Wu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here